Evidence map›Paper›PMID 27308383›Full record

ReviewMolecular & cellular oncology

Role of the double-strand break repair pathway in the maintenance of genomic stability.

Tangui Le Guen, Sandrine Ragu, Josée Guirouilh-Barbat, Bernard S Lopez

Abstract readReview
In one paragraph

Review in Molecular & cellular oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. The Oxidative Stress: Origin and Role in Aging and Diseases.Antioxidants (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Engineering the oleaginous yeastBiotechnology for biofuels · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tangui Le GuenUniversité Paris Sud; CNRS UMR 8200; Institut de Cancérologie Gustave-Roussy; Team labeled "Ligue 2014" ; Villejuif, France.
Sandrine RaguUniversité Paris Sud; CNRS UMR 8200; Institut de Cancérologie Gustave-Roussy; Team labeled "Ligue 2014" ; Villejuif, France.
Josée Guirouilh-BarbatUniversité Paris Sud; CNRS UMR 8200; Institut de Cancérologie Gustave-Roussy; Team labeled "Ligue 2014" ; Villejuif, France.
Bernard S LopezUniversité Paris Sud; CNRS UMR 8200; Institut de Cancérologie Gustave-Roussy; Team labeled "Ligue 2014" ; Villejuif, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA double-strand breaks (DSBs) are highly lethal lesions that jeopardize genome integrity. However, DSBs are also used to generate diversity during the physiological processes of meiosis or establishment of the immune repertoire. Therefore, DSB repair must be tightly controlled. Two main strategies are used to repair DSBs: homologous recombination (HR) and non-homologous end joining (NHEJ). HR is generally considered to be error-free, whereas NHEJ is considered to be error-prone. However, recent data challenge these assertions. Here, we present the molecular mechanisms involved in HR and NHEJ and the recently described alternative end-joining mechanism, which is exclusively mutagenic. Whereas NHEJ is not intrinsically error-prone but adaptable, HR has the intrinsic ability to modify the DNA sequence. Importantly, in both cases the initial structure of the DNA impacts the outcome. Finally, the consequences and applications of these repair mechanisms are discussed. Both HR and NHEJ are double-edged swords, essential for maintenance of genome stability and diversity but also able to generate genome instability.

Indexed as

DNA repairdouble-strand break repairgenome instabilitygenome rearrangementshomologous recombinationionizing radiationmutagenesisnon-homologous end joiningtelomeres

Identifiers

PMID27308383
PMCPMC4905226

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.